Pancreatic Cancer Trial, Recruiting NCT04136132 Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT04136132
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years of age
  • People being treated for pancreatic adenocarcinoma (a type of pancreatic cancer)
  • People whose medical team considers them suitable for at least one surgery and chemotherapy
  • People who are willing and able to give their informed consent to participate

Who may not be able to join:

  • People who are not covered by a social security (health insurance) scheme
  • People who are pregnant or breastfeeding
  • People who are under legal guardianship, curatorship, or a court-ordered protection arrangement
  • People for whom regular follow-up appointments would not be possible, due to psychological, family, social, or geographical reasons

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pierre-Emmanuel COLOMBO, MD, Institut Régional du Cancer de Montpellier (ICM)

Phone: 0467613102

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Registry
ClinicalTrials.gov
Start date
15 May 2019
Est. completion
1 June 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Proportion of patients who gave their consent to participate in the study

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov